April 16, 2015, 1:00 pm - 2:30 pm ET
Diabetic Agents An Old Problem: New Focus (Part 3 of 3)
As part of our continuing series on the Triple Threat of Anticoagulation, Opioid medications, and Diabetic agents, as discussed in The National Action Plan for Adverse Drug Event Prevention (ADE Action Plan), we invite you to join us for our third webinar of the series for an in-depth review of diabetic agents and strategies to mitigate risks of ADEs.
We are proud to have Dr. Mary Andrawis, PharmD, MPH, Senior Advisor, Centers for Medicare & Medicaid Innovation, as our first speaker. Dr. Andrawis will speak extensively on the topic of anti-diabetic agents and the use and misuse of anti-diabetic medications. According to 2010 data from the Medicare Patient Safety Monitoring System (MPSMS) on ADEs, 57 percent nationally are due to hypoglycemic agents. Hypoglycemic agents cause complications in both inpatient and outpatient settings. Dr. Andrawis will discuss current strategies to optimize anti-diabetic agent use in the context of the "Inpatient: Scope of Problem and Challenges."
Our second speaker will be Leonard Pogach, MD, MBA, FACP, who will provide an overview on the "Prevention of Serious Hypoglycemic Events in Outpatient Settings." Dr. Pogach is the National Director of Medicine at Veterans Affairs Central Office, and is a recognized national expert, currently focusing on use of large administrative data sets to evaluate ambulatory quality of care and their impact upon prevention quality indicators among veterans with diabetes.
After the presentations, our speakers will be joined by members of a reactor panel who will discuss the key takeaways with our experts, and will respond to questions from our webinar participants.
Click here to download the combined speakers' slide set in PDF format one (1) slide per page.
Click here to download the combined speakers' slide set in PDF format four (4) slides per page.
To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose "Save Target As." (In some browsers it might say "Save Link As.")
The slide set could take several minutes to download. The "four per page" slide set may download more efficiently.
Registration Information and CE Credit Information:
Register: Click here to register for this Webinar.
When:April 16, 2015 Time: 1:00 p.m.-2:30 p.m. ET
We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to email@example.com with the session title in the e-mail message header.
Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.
Participants will be informed on:
Awareness: Participants will understand and be able to communicate the frequency, severity, and preventability of certain errors, harm, and harm due to errors related to the use of diabetic agents.
Accountability: Participants will understand WHO is accountable for new behaviors to protect patients and caregivers from errors and harm related to the use of diabetic agents.
Ability: Participants will learn the principles of importance in education and how to enable key actors to reduce errors and harm related to the use of diabetic agents.
Action: Participants will learn what direct line-of-sight actions must be taken to prevent and reduce the harm or ADEs related to the use of diabetic agents.
CE Participation Documentation
Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar.
To request a Participation Document, please click here.
Mary A. Andrawis, PharmD, MPH Adverse Drug Events Old Problem, New Focus: Diabetic Agents
Mary A. Andrawis, PharmD, MPH, is a Senior Advisor at the Centers for Medicare & Medicaid Innovation in Baltimore, MD. Dr. Andrawis trained in pharmacy leadership through Johns Hopkins Hospital's Pharmacy Administration residency in Baltimore, MD, a two-year program combining intense clinical activities with administrative training in quality improvement, patient safety, and emergency preparedness.
Leonard Pogach, MD, MBA Diabetic Agents Adverse Drug Event Prevention
Leonard Pogach, MD, MBA, FACP, was graduated from the University of Pennsylvania, received his MD degree from Hahnemann Medical College; completed an Internal Medicine Residency at Temple University Health Sciences Center; was awarded a fellowship in Endocrinology and Metabolism at Boston University Health Sciences Center; and obtained a Masters in Business Administration from Seton Hall University. He spent his postgraduate career at the Department of Veterans Affairs New Jersey Health Care System (VANJHCS)/East Orange VA Medical Center from 1981 to 2012, before assuming his current position as the National Director for Medicine, Office of Specialty Care/Patient Care Services, Veterans Affairs Central Office.
Patient Safety Advocate
Jennifer Dingman Discussion and Reaction to Presentations AND The Voice of Patient and Family
Jennifer Dingman realized, after her mother's death in 1995 due to errors in medical diagnoses and treatment, that there is little to no help available for patients and their families in similar situations. This life-changing experience left her feeling vulnerable, and she decided to dedicate her life to help prevent medical tragedies from happening to others.
Moderator and Introduction
Charles R. Denham, MD Welcome and Introduction
During Dr. Denham's business development career spanning 30 years, he and his organizations have served hundreds of innovation teams. While in practice as a radiation oncologist, he taught biomedical engineering and product development. He has taught innovation adoption, technology transfer, and commercialization in both academia and industry. He has been an adjunct Professor of Health Services Engineering at the...
Franck Guilloteau Discussion and Reaction to Presentations
During the past 20 years with HCC Corporation, Franck Guilloteau has led multiple projects, spanning industry segments from aerospace and consumer products to software and fitness. As Chief Technology Officer, Mr. Guilloteau takes the lead role in developing Software as a Service (SaaS) offerings and knowledge management systems used by HCC's global partners, while keeping HCC on the leading edge of technological advancements in multimedia, IT, e-commerce, and product development.
Levinson DR. Adverse events in hospitals: national incidence among Medicare beneficiaries. Office of Inspector General. OEI-06-09-00090. Washington, DC: U.S. Department of Health and Human Services; 2010 Nov. Available at http://oig.hhs.gov/oei/reports/oei-06-09-00090.pdf
Levinson DR. Adverse events in skilled nursing facilities: national incidence among Medicare beneficiaries. Office of Inspector General OEI-06-11-00370. Washington, DC: U.S. Department of Health and Human Services; 2014 Feb. Available at http://oig.hhs.gov/oei/reports/oei-06-11-00370.pdf
U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: U.S. Department of Health and Human Services; 2014. Available at http://www.health.gov/hai/pdfs/ADE-Action-Plan-508c.pdf.